Beryl Drugs Ltd

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi

Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi

Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →

Newspaper Publication

NEWSPAPER PUBLICATION OF UNAUDITED QUARTERLY FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE, 2026

Company Update / Newspaper Publication View filing →

Board Meeting Intimation for Consider And Approve The Unaudited Financial Results For The Quarter Ended 30Th June, 2026

Beryl Drugs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the unaudited financial results ....

Board Meeting / Board Meeting View filing →

Intimation Regarding Temporary Unavailability Of The Company's Website Due To An Unexpected Technical Issue

TEMPORARY UNAVAILABILITY OF THE COMPANY'S WEBSITE "www.beryldrugs.com" DUE TO AN UNEXPECTED TECHNICAL ISSUE.

Company Update / General View filing →

Compliance-57 (5) : intimation after the end of quarter

NON-APPLOCABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30TH JUNE, 2026

Others / 57 (5) : intimation after the end of quarter View filing →

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

CERTIFICATE UNDER REGULATION 74(5) OF SEBI (DP) REGULATIONS, 2018

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

Closure of Trading Window

CLOSURE OF TRADING WINDOW FOR THE QUARTER ENDED 30.06.2026

Insider Trading / SAST / Closure of Trading Window View filing →

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi

Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

Change in Registered Office Address

CHANGE IN REGISTERED OFFICE OF THE COMPANY FROM 133, KANCHAN BAGH, INDORE TO 29, NEER NAGAR, MAYANK WATER PARK ROAD, BICHOLI, INDORE WITHIN LOCAL LIMITS OF SAME CITY

Company Update / Change in Registered Office Address View filing →

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi

Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi

Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi

Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi

Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

Board Meeting Intimation for CHANGE IN REGISTERED OFFICE OF THE COMPANY

Beryl Drugs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/06/2026 ,inter alia, to consider and approve change in registered office of ....

Board Meeting / Board Meeting View filing →